These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
77 related items for PubMed ID: 10806144
1. Additive effects of phosphodiesterase-4 inhibition on effects of rSP-C surfactant. Häfner D, Germann PG. Am J Respir Crit Care Med; 2000 May; 161(5):1495-500. PubMed ID: 10806144 [Abstract] [Full Text] [Related]
2. Cyclooxygenase-inhibition enhances the effects of rSP-C surfactant therapy in a rat lavage model of acute respiratory distress syndrome (ARDS). Häfner D, Ibrahim M, Wollin L, Germann PG. Exp Toxicol Pathol; 2003 Jul; 55(1):59-68. PubMed ID: 12940630 [Abstract] [Full Text] [Related]
3. Effects of early treatment with rSP-C surfactant on oxygenation and histology in rats with acute lung injury. Häfner D, Germann PG, Hauschke D, Kilian U. Pulm Pharmacol Ther; 1999 Jul; 12(3):193-201. PubMed ID: 10419839 [Abstract] [Full Text] [Related]
4. A rat model of acute respiratory distress syndrome (ARDS) Part 2, influence of lavage volume, lavage repetition, and therapeutic treatment with rSP-C surfactant. Häfner D, Germann PG. J Pharmacol Toxicol Methods; 1999 Jul; 41(2-3):97-106. PubMed ID: 10598681 [Abstract] [Full Text] [Related]
5. Comparison of rSP-C surfactant with natural and synthetic surfactants after late treatment in a rat model of the acute respiratory distress syndrome. Häfner D, Germann PG, Hauschke D. Br J Pharmacol; 1998 Jul; 124(6):1083-90. PubMed ID: 9720777 [Abstract] [Full Text] [Related]
6. Dexamethasone enhances the activity of rSP-C surfactant but not of exosurf in a rat model of the acute lung injury. Häfner D, Germann PG. J Pharmacol Toxicol Methods; 1999 Sep; 42(1):39-48. PubMed ID: 10715602 [Abstract] [Full Text] [Related]
7. Effects of rSP-C surfactant on oxygenation and histology in a rat-lung-lavage model of acute lung injury. Häfner D, Germann PG, Hauschke D. Am J Respir Crit Care Med; 1998 Jul; 158(1):270-8. PubMed ID: 9655740 [Abstract] [Full Text] [Related]
8. Effects of C1 inhibitor and r-SP-C surfactant on oxygenation and histology in rats with lavage-induced acute lung injury. Vangerow B, Häfner D, Rueckoldt H, Marx G, Ott N, Leuwer M, Frerking I, Germann PG. Intensive Care Med; 2001 Sep; 27(9):1526-31. PubMed ID: 11685347 [Abstract] [Full Text] [Related]
9. Intratracheally applied rSP-C surfactant exhibits no anaphylactic shock reactions in a guinea pig model of acute lung hypersensitivity. Germann PG, Kemkowski J, Hauschke D, Steinhilber W, Häfner D. Exp Toxicol Pathol; 1999 Nov; 51(6):495-505. PubMed ID: 10661808 [Abstract] [Full Text] [Related]
10. Dosing and delivery of a recombinant surfactant in lung-injured adult sheep. Lewis J, McCaig L, Häfner D, Spragg R, Veldhuizen R, Kerr C. Am J Respir Crit Care Med; 1999 Mar; 159(3):741-7. PubMed ID: 10051245 [Abstract] [Full Text] [Related]
11. Surfactant and inhaled nitric oxide in rats alleviate acute lung injury induced by intestinal ischemia and reperfusion. Zheng S, Zhang WY, Zhu LW, Lin K, Sun B. J Pediatr Surg; 2001 Jul; 36(7):980-4. PubMed ID: 11431761 [Abstract] [Full Text] [Related]
13. Suppression of acute lung injury in mice by an inhibitor of phosphodiesterase type 4. Miotla JM, Teixeira MM, Hellewell PG. Am J Respir Cell Mol Biol; 1998 Mar; 18(3):411-20. PubMed ID: 9490659 [Abstract] [Full Text] [Related]
14. Phosphodiesterase type 4 inhibitor prevents acute lung injury induced by cardiopulmonary bypass in a rat model. Hamamoto M, Suga M, Nakatani T, Takahashi Y, Sato Y, Inamori S, Yagihara T, Kitamura S. Eur J Cardiothorac Surg; 2004 May; 25(5):833-8. PubMed ID: 15082290 [Abstract] [Full Text] [Related]
15. Effects of lung surfactant factor (LSF) treatment on gas exchange and histopathological changes in an animal model of adult respiratory distress syndrome (ARDS): comparison of recombinant LSF with bovine LSF. Häfner D, Germann PG, Hauschke D. Pulm Pharmacol; 1994 Oct; 7(5):319-32. PubMed ID: 7626919 [Abstract] [Full Text] [Related]
16. Effect of recombinant SP-C surfactant in a porcine lavage model of acute lung injury. Spragg RG, Smith RM, Harris K, Lewis J, Häfner D, Germann P. J Appl Physiol (1985); 2000 Feb; 88(2):674-81. PubMed ID: 10658037 [Abstract] [Full Text] [Related]
17. Lung function in premature rabbits treated with recombinant human surfactant protein-C. Hawgood S, Ogawa A, Yukitake K, Schlueter M, Brown C, White T, Buckley D, Lesikar D, Benson B. Am J Respir Crit Care Med; 1996 Aug; 154(2 Pt 1):484-90. PubMed ID: 8756826 [Abstract] [Full Text] [Related]
18. Combined surfactant therapy and inhaled nitric oxide in rabbits with oleic acid-induced acute respiratory distress syndrome. Zhu GF, Sun B, Niu SF, Cai YY, Lin K, Lindwall R, Robertson B. Am J Respir Crit Care Med; 1998 Aug; 158(2):437-43. PubMed ID: 9700118 [Abstract] [Full Text] [Related]
19. Recombinant surfactant protein C-based surfactant for patients with severe direct lung injury. Spragg RG, Taut FJ, Lewis JF, Schenk P, Ruppert C, Dean N, Krell K, Karabinis A, Günther A. Am J Respir Crit Care Med; 2011 Apr 15; 183(8):1055-61. PubMed ID: 21148720 [Abstract] [Full Text] [Related]
20. Characterization of the cyclic nucleotide phosphodiesterase subtypes involved in the regulation of the L-type Ca2+ current in rat ventricular myocytes. Verde I, Vandecasteele G, Lezoualc'h F, Fischmeister R. Br J Pharmacol; 1999 May 15; 127(1):65-74. PubMed ID: 10369457 [Abstract] [Full Text] [Related] Page: [Next] [New Search]